| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 14.602 | 26.830 | 33.389 | 35.804 | 53.588 | 62.752 | 85.576 | 120.800 |
| Total Income - EUR | - | - | 14.603 | 26.830 | 33.389 | 35.804 | 53.588 | 62.752 | 86.436 | 123.311 |
| Total Expenses - EUR | - | - | 1.386 | 5.287 | 5.214 | 4.371 | 5.084 | 6.260 | 13.735 | 17.922 |
| Gross Profit/Loss - EUR | - | - | 13.216 | 21.543 | 28.175 | 31.433 | 48.504 | 56.491 | 72.701 | 105.389 |
| Net Profit/Loss - EUR | - | - | 12.778 | 20.738 | 27.174 | 30.426 | 46.929 | 55.078 | 71.854 | 101.764 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Rheumatica Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 7.456 | 5.450 | 3.512 | 2.283 | 395 | 606 | 2.131 | 14.054 |
| Current Assets | - | - | 6.019 | 15.590 | 24.041 | 28.658 | 47.024 | 67.390 | 70.529 | 94.153 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 18.794 | 9.952 | 22.254 | 38.528 | 48.721 | 72.602 |
| Cash | - | - | 6.019 | 15.590 | 5.247 | 18.707 | 24.770 | 7.570 | 1.995 | 1.448 |
| Shareholders Funds | - | - | 12.822 | 20.781 | 27.224 | 30.475 | 46.977 | 55.127 | 71.903 | 101.812 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 653 | 258 | 329 | 466 | 442 | 12.905 | 757 | 6.395 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rheumatica Plus Srl